ClinicalTrials.gg
Active, not recruitingNCT07341633AIS-DTx-RCTUpdated Apr 23, 2026

AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

An interventional study of AI-Based Digital Therapeutic System and Standard Outpatient Schroth Therapy in Adolescent Idiopathic Scoliosis (AIS), sponsored by Jinan University Guangzhou. Active, not recruiting at 1 site in China. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Jinan University Guangzhou · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 55 studies in Scoliosis with a site in China — 22 open to participants now, 26 under way, none of them phase 3. Scoliosis · China.

Planned enrollment
6th of 37
300 · median 100
Started
2026
with 4 others
No phase
31 of 55
14 open now
Primary completion
2028-01
later than 22 of 25 live
Registered
50th of 55
by date

Among the 55 studies in Scoliosis with a site in China, this one is the 6th largest by planned enrollment of the 37 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, reaches primary completion later than 22 of the 25 other live ones, and was the 50th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

22 of the 55 studies in Scoliosis with a site in China are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 55 studies in Scoliosis with a site in China, or all of them as a file.
02

Study summary

This randomized controlled trial (RCT) evaluates the efficacy of a novel Artificial Intelligence (AI)-based digital therapeutic system compared to traditional outpatient Schroth exercises for the treatment of Adolescent Idiopathic Scoliosis (AIS). The intervention utilizes a smartphone application with computer vision technology to perform remote, personalized posture analysis and generate adaptive exercise prescriptions. The study aims to determine if this "Human-in-the-Loop" AI model demonstrates superior clinical outcomes in controlling spinal curve progression and improving treatment adherence compared to standard conservative care over a 6-month period.

Read the detailed description

Background: Adolescent Idiopathic Scoliosis (AIS) requires long-term conservative management to prevent curve progression. While Physiotherapeutic Scoliosis Specific Exercises (PSSE), such as the Schroth method, are the gold standard, their efficacy is often limited by accessibility barriers and suboptimal adherence.

Study Design: This is a parallel-group, single-blind randomized controlled trial. A total of 300 eligible adolescents (aged 10-18, Cobb angle 10-30°, Risser sign 0-2) will be randomized in a 1:1 ratio into an Intervention Group or a Control Group.

Interventions:

Intervention Group (AI-DTx): Participants utilize a smartphone application to capture standardized photos every two weeks. An AI algorithm (based on MediaPipe) extracts skeletal landmarks to classify curve patterns and assign personalized exercise modules. The system features a "Check-and-Adjust" matrix to adapt exercise intensity based on metric changes. A Clinical Research Assistant (Human-in-the-Loop) verifies all prescriptions for safety before release.

Control Group (Standard Care): Participants receive standard outpatient Schroth therapy, involving daily home exercises and monthly supervised clinic visits, following SOSORT guidelines.

Objectives: The primary objective is to evaluate the absolute change in the major curve Cobb angle from baseline to six months. Secondary outcomes include the Angle of Trunk Rotation (ATR), trunk appearance perception (TAPS), quality of life (SRS-22r), and adherence rates. The study hypothesizes that the AI-driven intervention will demonstrate superior efficacy and adherence compared to traditional outpatient care.

03

Conditions studied

  • Adolescent Idiopathic Scoliosis (AIS)

Browse trials for

Keywords

  • Digital Therapeutics
  • Artificial Intelligence
  • Schroth Method
  • Tele-rehabilitation
  • Computer Vision
  • Scoliosis
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of Adolescent Idiopathic Scoliosis (AIS).
  2. Age between 10 and 18 years (inclusive).
  3. Cobb angle of the major curve between 10° and 30°.
  4. Risser sign 0-2 (indicating skeletal immaturity).
  5. Ability to operate a smartphone and follow instructions for the digital therapeutic application.
  6. Patient and legal guardian provide written .

Exclusion criteria

Exclusion Criteria:

  1. Non-idiopathic scoliosis (e.g., congenital, neuromuscular, or syndromic etiology).
  2. History of prior spinal surgery or currently scheduled for surgery.
  3. to exercise therapy (e.g., cardiac or respiratory insufficiency).
  4. Severe cognitive or psychiatric disorders that prevent compliance with the protocol.
  5. Currently receiving other scoliosis-specific treatments (e.g., bracing) outside of the study protocol (unless stratified).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Standard Outpatient Schroth Therapy

    Participants receive standard conservative care based on Schroth Best Practice guidelines. This involves an initial 60-minute comprehensive evaluation, followed by a personalized home exercise program (30 minutes daily). Participants attend monthly supervised sessions at the outpatient clinic for manual prescription adjustments by a certified therapist .

    Behavioral: Standard Outpatient Schroth Therapy

  • Experimental
    AI-Based Digital Therapeutics (AI-DTx)

    Participants utilize a smartphone application to capture standardized photos every two weeks. An AI algorithm (MediaPipe-based) processes these images to classify curve patterns and assign personalized exercise modules. The system uses a "Human-in-the-Loop" workflow where a Clinical Research Assistant verifies the AI-generated prescription before release. Dosing intensity is adaptively adjusted based on metric changes.

    Device: AI-Based Digital Therapeutic System

Interventions

  • DeviceAI-Based Digital Therapeutic System

    A smartphone-based digital therapeutic application that utilizes computer vision (MediaPipe Framework) to capture and analyze patient posture bi-weekly. The system employs a hierarchical triage logic to classify curve patterns and assign personalized Schroth-based exercise modules. It features a "Human-in-the-Loop" safety protocol where a Clinical Research Assistant validates the AI-generated prescription before release. The exercise dosing (intensity and props) is adaptively adjusted based on the calculated metric changes (NSI) every two weeks .

  • BehavioralStandard Outpatient Schroth Therapy

    Standard conservative management based on the SOSORT and Schroth Best Practice guidelines. Participants undergo an initial 60-minute comprehensive evaluation and education session. The intervention consists of a daily home exercise program (30 minutes/day) and mandatory monthly face-to-face supervised sessions at the outpatient clinic, where a certified therapist manually adjusts the exercise prescription based on clinical progression .

06

What researchers measure

Primary outcomes

  1. Absolute Change in Major Curve Cobb Angle

    Measured on standardized standing posteroanterior full-spine radiographs. The Cobb angle is the angle formed between the upper endplate of the most tilted upper vertebra and the lower endplate of the most tilted lower vertebra. Measurements are performed in degrees by independent radiologists who are blinded to group allocation. A negative value indicates a reduction (improvement) in the spinal curve.

    Time frame: Baseline, 3 months, and 6 months

Secondary outcomes

  1. Treatment Adherence Rate

    Calculated as the percentage of completed exercise sessions relative to the prescribed sessions. For the Intervention group, adherence is logged automatically by the app via computer vision verification. For the Control group, adherence is self-reported via paper logs.

    Time frame: Baseline, 3 months, and 6 months

  2. Change in Angle of Trunk Rotation (ATR)

    Measured using a Scoliometer during the Adam's Forward Bend Test. The maximum rotation angle of the trunk is recorded in degrees.

    Time frame: Baseline, 3 months, and 6 months

  3. Change in Quality of Life (SRS-22r Score)

    Assessed using the Scoliosis Research Society-22 revised (SRS-22r) questionnaire. The score ranges from 1 to 5, with higher scores indicating better patient outcomes across domains of function, pain, self-image, and mental health.

    Time frame: Baseline, 3 months, and 6 months

  4. Change in Trunk Appearance Perception (TAPS)

    Assessed using the Trunk Appearance Perception Scale (TAPS), a patient-reported outcome measure of self-perceived trunk deformity. Scores range from 1 (worst) to 5 (best).

    Time frame: Baseline, 3 months, and 6 months

07

Study locations

1 site
08

References and documents

Publications

  • Ma R, Huang Z, Zhu X, Ma X, Cheng W, Tang D, Liu J, Shu L. Efficacy of artificial intelligence-based digital therapeutics versus traditional Schroth exercises for adolescent idiopathic scoliosis: protocol for a randomised controlled trial. BMJ Open. 2026 May 24;16(5):e116834. doi: 10.1136/bmjopen-2026-116834. PubMed 42192639 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the published results, including baseline demographics, Risser sign, Cobb angle, Angle of Trunk Rotation, TAPS scores, SRS-22r scores, and adherence metrics for all randomised participants, will be made available. All data will be anonymised prior to sharing; no facial images or directly identifying information will be released.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 9 months after publication of the primary results article and ending 36 months thereafter.

Access criteria: Access will be granted to qualified researchers whose proposed use has been approved by an independent review committee for the purpose of individual participant data meta-analyses or methodologically sound secondary analyses. Requests should be directed to the corresponding author (penny@link.cuhk.edu.hk) and must include a detailed research proposal, a statistical analysis plan, and evidence of ethical approval from the requester's institution. Data will be shared through a secure data transfer platform following the execution of a signed Data Use Agreement.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Jan 2028, 23 months after the start.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 23 months is close to that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2026
First posted
Jan 14, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Jan 1, 2028
CompletionEst.
Jan 1, 2028
Last update
Apr 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07341633
Lead sponsor
Jinan University Guangzhou
Collaborators
Guangzhou Women and Children's Medical Center
Responsible party
Ma Ruisi (Lecturer, Jinan University Guangzhou) — Principal investigator
First posted
Jan 14, 2026
Start date
Feb 1, 2026
Primary completion
Jan 1, 2028 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Apr 23, 2026

Study contacts

Lili Shu, MD
principal investigator · Guangzhou Women and Children's Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion